Wanglong Qiu

1.8k total citations
32 papers, 1.4k citations indexed

About

Wanglong Qiu is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Wanglong Qiu has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Wanglong Qiu's work include Pancreatic and Hepatic Oncology Research (19 papers), TGF-β signaling in diseases (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Wanglong Qiu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), TGF-β signaling in diseases (6 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Wanglong Qiu collaborates with scholars based in United States, Germany and China. Wanglong Qiu's co-authors include Gloria H. Su, Frank Schönleben, Helen Remotti, Daniel Ho, John Allendorf, Lanny Garth Close, Xiaojun Li, Spiros Manolidis, Boyce Bennett and Ralph H. Hruban and has published in prestigious journals such as Gastroenterology, PLoS ONE and Oncogene.

In The Last Decade

Wanglong Qiu

32 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanglong Qiu United States 21 841 672 319 318 224 32 1.4k
Dakeun Lee South Korea 23 581 0.7× 603 0.9× 304 1.0× 313 1.0× 346 1.5× 74 1.4k
Meghna Waghray United States 15 623 0.7× 663 1.0× 229 0.7× 261 0.8× 299 1.3× 15 1.4k
Patrícia Castro Portugal 20 666 0.8× 673 1.0× 257 0.8× 156 0.5× 117 0.5× 28 1.9k
T Tokunaga Japan 22 641 0.8× 942 1.4× 216 0.7× 438 1.4× 300 1.3× 36 1.6k
Awad Jarrar United States 14 736 0.9× 651 1.0× 212 0.7× 350 1.1× 265 1.2× 26 1.5k
Katsunari Yane Japan 17 960 1.1× 362 0.5× 279 0.9× 168 0.5× 293 1.3× 70 1.5k
Naoki Takahashi Japan 17 841 1.0× 515 0.8× 298 0.9× 349 1.1× 435 1.9× 89 1.6k
Elisabeth Heßmann Germany 17 750 0.9× 773 1.2× 153 0.5× 305 1.0× 105 0.5× 39 1.3k
Peng–Yuan Zhuang China 16 706 0.8× 700 1.0× 182 0.6× 491 1.5× 191 0.9× 28 1.8k
Po Min Chen Taiwan 8 654 0.8× 730 1.1× 96 0.3× 626 2.0× 155 0.7× 16 1.4k

Countries citing papers authored by Wanglong Qiu

Since Specialization
Citations

This map shows the geographic impact of Wanglong Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanglong Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanglong Qiu more than expected).

Fields of papers citing papers by Wanglong Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanglong Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanglong Qiu. The network helps show where Wanglong Qiu may publish in the future.

Co-authorship network of co-authors of Wanglong Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanglong Qiu. A scholar is included among the top collaborators of Wanglong Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanglong Qiu. Wanglong Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Wanglong, Richard A. Friedman, Iok In Christine Chio, et al.. (2022). Inactivation of Notch4 Attenuated Pancreatic Tumorigenesis in Mice. Cancer Research Communications. 2(12). 1601–1616. 2 indexed citations
2.
Han, Yan, Yeran Yang, Jun Yan, et al.. (2021). Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1. Oncogene. 40(50). 6759–6771. 17 indexed citations
3.
García‐Carracedo, Darío, Yi Cai, Wanglong Qiu, et al.. (2020). PIK3CA and p53 Mutations Promote 4NQO-Initated Head and Neck Tumor Progression and Metastasis in Mice. Molecular Cancer Research. 18(6). 822–834. 18 indexed citations
4.
Han, Yan, Wanglong Qiu, Jishu Wei, et al.. (2018). HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Cancer Letters. 442. 333–340. 57 indexed citations
5.
Qiu, Wanglong, Helen Remotti, Elizabeth Wang, et al.. (2018). Pancreatic DCLK1+ cells originate distinctly from PDX1+ progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice. Cancer Letters. 423. 71–79. 15 indexed citations
6.
Cheng, Haiying, Murali Janakiram, Alain Borczuk, et al.. (2016). HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status. Clinical Cancer Research. 23(3). 825–832. 83 indexed citations
7.
Yu, Chih‐Chieh, Wanglong Qiu, Caroline S. Juang, et al.. (2016). Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications. Cancer Letters. 384. 86–93. 26 indexed citations
8.
Qiu, Wanglong, Andrew T. Turk, Anthony Sireci, et al.. (2015). Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. Gastroenterology. 150(1). 218–228.e12. 33 indexed citations
9.
García‐Carracedo, Darío, et al.. (2014). PIK3CA Mutations in Mucinous Cystic Neoplasms of the Pancreas. Pancreas. 43(2). 245–249. 42 indexed citations
10.
Mao, Yuehua, Wanglong Qiu, Nicholas Cassai, et al.. (2013). Redirecting Apoptosis to Aponecrosis Induces Selective Cytotoxicity to Pancreatic Cancer Cells through Increased ROS, Decline in ATP Levels, and VDAC. Molecular Cancer Therapeutics. 12(12). 2792–2803. 19 indexed citations
11.
Qiu, Wanglong & Gloria H. Su. (2012). Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis. Cancer and Metastasis Reviews. 32(1-2). 83–107. 28 indexed citations
12.
Qiu, Wanglong & Gloria H. Su. (2012). Development of Orthotopic Pancreatic Tumor Mouse Models. Methods in molecular biology. 980. 215–223. 76 indexed citations
13.
DiNorcia, Joseph, Minna K. Lee, Dorota Moroziewicz, et al.. (2011). RAGE Gene Deletion Inhibits the Development and Progression of Ductal Neoplasia and Prolongs Survival in a Murine Model of Pancreatic Cancer. Journal of Gastrointestinal Surgery. 16(1). 104–112. 37 indexed citations
14.
Qiu, Wanglong, et al.. (2010). Conditional Activin Receptor Type 1B (Acvr1b) Knockout Mice Reveal Hair Loss Abnormality. Journal of Investigative Dermatology. 131(5). 1067–1076. 44 indexed citations
15.
Bruckman, Karl C., Frank Schönleben, Wanglong Qiu, Victoria Woo, & Gloria H. Su. (2010). Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 110(5). 632–637. 33 indexed citations
16.
Schönleben, Frank, Wanglong Qiu, Helen Remotti, Werner Hohenberger, & Gloria H. Su. (2008). PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas. Langenbeck s Archives of Surgery. 393(3). 289–296. 57 indexed citations
17.
Schönleben, Frank, John Allendorf, Wanglong Qiu, et al.. (2008). Mutational Analyses of Multiple Oncogenic Pathways in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas. 36(2). 168–172. 32 indexed citations
18.
Qiu, Wanglong, Guo‐Xia Tong, Spiros Manolidis, et al.. (2007). Novel mutant‐enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer. International Journal of Cancer. 122(5). 1189–1194. 42 indexed citations
19.
Qiu, Wanglong, Frank Schönleben, Xiaojun Li, & Gloria H. Su. (2006). Disruption of transforming growth factor β-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Cancer Letters. 245(1-2). 163–170. 59 indexed citations
20.
Şahιn, Fikrettin, Wanglong Qiu, Robb E. Wilentz, et al.. (2005). RPL38, FOSL1, and UPP1 Are Predominantly Expressed in the Pancreatic Ductal Epithelium. Pancreas. 30(2). 158–167. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dakeun Lee Breakdown of academic impact, for papers by Meghna Waghray Breakdown of academic impact, for papers by Patrícia Castro Breakdown of academic impact, for papers by T Tokunaga Breakdown of academic impact, for papers by Awad Jarrar Breakdown of academic impact, for papers by Katsunari Yane Breakdown of academic impact, for papers by Naoki Takahashi Breakdown of academic impact, for papers by Elisabeth Heßmann Breakdown of academic impact, for papers by Peng–Yuan Zhuang Breakdown of academic impact, for papers by Po Min Chen
Rankless by CCL
2026